Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited)

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Balance, beginning at Dec. 31, 2019 $ (11,053) $ 48 $ 215,207 $ (79) $ (226,229)
Balance, beginning (in shares) at Dec. 31, 2019   48,471,446      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Fair value of warrants including down-round protection adjustments 400   600   (200)
Common stock issued for cash (net of issuance cost) 142 $ 1 141    
Common stock issued for cash (net of issuance cost), shares   515,743      
Share-based compensation 209   209    
Foreign currency translation effect 61     61  
Net income (loss) 5,509       5,509
Balance, ending at Mar. 31, 2020 (4,732) $ 49 216,157 (18) (220,920)
Balance, ending (in shares) at Mar. 31, 2020   48,987,189      
Balance, beginning at Dec. 31, 2020 (5,158) $ 49 218,728 1,144 (225,079)
Balance, beginning (in shares) at Dec. 31, 2020   48,987,189      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Fair value of warrants including down-round protection adjustments     241   (241)
Common stock issued for services 500   500    
Common stock issued for services, shares   324,675      
Share-based compensation 181   181    
Unrealized gain on debt securities available for sale (net of tax) 58     58  
Foreign currency translation effect 165     165  
Net income (loss) (8,422)       (8,422)
Balance, ending at Mar. 31, 2021 $ (12,676) $ 49 $ 219,650 $ 1,367 $ (233,742)
Balance, ending (in shares) at Mar. 31, 2021   49,311,864